|1.||Morgenthaler, Nils G: 4 articles (04/2014 - 01/2008)|
|2.||Struck, Joachim: 3 articles (11/2012 - 01/2008)|
|3.||Mueller, Christian: 2 articles (01/2010 - 01/2008)|
|4.||Christ-Crain, Mirjam: 2 articles (08/2008 - 01/2008)|
|5.||Tamm, Michael: 2 articles (08/2008 - 01/2008)|
|6.||Stolz, Daiana: 2 articles (08/2008 - 01/2008)|
|7.||Bingisser, Roland: 2 articles (08/2008 - 01/2008)|
|8.||Latini, Roberto: 1 article (05/2015)|
|9.||Scarano, Marco: 1 article (05/2015)|
|10.||Tavazzi, Luigi: 1 article (05/2015)|
|1.||Hypertension (High Blood Pressure)
11/01/1998 - "In addition, the increase in ET-1 levels was significantly greater in patients with interdialysis hypertension, while changes in proET-1 level were similar in both hypertensive and non-hypertensive groups. "
11/01/1998 - "In patients with significant interdialysis hypertension following a single i.v. injection of rHuEpo, the molar ratio of ET-1 over proET-1 (ET-1/proET-1) was significantly higher than in patients without hypertension. "
11/01/1998 - "However there is no report on whether a change in the rate of conversion of proET-1 to ET-1 may be involved in the pathogenesis of rHuEpo-induced hypertension. "
11/01/2012 - "The aim of this study was to investigate the association between plasma COOH-terminal proendothelin-1 (CT-proET-1) and fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in patients with type 2 diabetes. "
04/01/2014 - "Multivariable linear regression models revealed that sKlotho was independently associated with proET-1 after adjustment for renal filtration function, albuminuria, diabetes duration, HbA1c, systolic and diastolic blood pressure. "
11/01/2012 - "Plasma COOH-terminal proendothelin-1: a marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? "
|3.||Renal Insufficiency (Renal Failure)
|4.||Chronic Obstructive Pulmonary Disease (COPD)
|5.||Septic Shock (Toxic Shock Syndrome)
12/01/2010 - "The objective of the present study was to concomitantly assess the predictive value of C-terminal proendothelin-1 and midregional proatrial natriuretic peptide (CT-proET-1 and MR-proANP, respectively vasoconstrictor and vasodilator) on 28-day mortality following septic shock. "
12/01/2010 - "Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1."
|4.||Biological Markers (Surrogate Marker)